Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Corneal Neovascularization D016510 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
HIV Infections D015658 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Izumi T et al. Regulation and signal transduction of PAF receptor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732892
Bennett SA and Birnboim HC Platelet activating factor induces transformation of human fibroblasts. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732893
Vargaftig BB et al. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221558
Voelkel NF et al. Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221590
Summers JB et al. ABT-299, a potent antagonist of platelet activating factor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732895
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Shen TY et al. Recent development of platelet-activating factor antagonists. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546389
Handley DA et al. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546390
Dray F et al. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546391
Takatani M et al. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825438
Kawabe T et al. Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825444
Weber PC and Sellmayer A Modification of the eicosanoid system and cell signalling by precursor fatty acids. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825543
Balazy M et al. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825562
Magni F et al. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825563
Coceani F et al. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825586